Stock Movers: McDonald's Sales Decline, CVS Drug Deal, Qualcomm Forecast, Nvidia AI Exports

McDonald's Sales Slump

• 🍟 McDonald's shares are down due to a 3.6% drop in U.S. same-store sales in the first quarter, the largest decline since Q2 2020.
• 💡 Despite efforts like affordable menus and limited-time offers, the company is struggling to attract customers, mirroring trends seen at Chipotle and Starbucks.
• 📉 The CEO expressed confidence in gaining market share, but the stock performance indicates ongoing challenges.

CVS Health's Strategic Moves

• 📈 CVS shares rose significantly following news that its Caremark division negotiated a deal to increase the availability of Novo Nordisk's weight-loss drug, Wegovy, to its members.
• ⚠️ This move impacts competitors, with Eli Lilly's drugs (like Zepbound) potentially becoming more expensive for insurers and employers using CVS Caremark, starting July 1st.
• 🏥 Additionally, CVS's Aetna unit is exiting the Affordable Care Act insurance markets in 2025 due to unstable performance and financial losses.

Qualcomm's Revenue Concerns

• 📉 Qualcomm's revenue forecast fell below estimates, leading to a stock price decrease.
• 📱 This outlook raises concerns about the impact of tariffs on demand in the smartphone market, Qualcomm's largest.
• 📊 Similar cautious outlooks have been issued by other chipmakers like Intel, suggesting a broader trend affecting the industry.

Nvidia and AI Export Regulations

• 🚀 Nvidia shares saw an increase after CEO Jensen Huang advocated for changes to U.S. export regulations concerning artificial intelligence technology.
• 🤝 Huang urged President Trump to modify rules to facilitate the export of AI technology globally.